FormanBiotech Holding ApS: Financial statements 2025
CVR: 42542849
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
FormanBiotech Holding ApS (CVR 42542849) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -4,876 and a net result of DKK 85,326 compared with DKK -2,512,116 the year before. Equity in the 2025 report amounted to DKK 4,313,203. The solvency ratio was 100%.
- Gross Profit
- DKK -4,876
- Profit/Loss
- DKK 85,326
- Equity
- DKK 4,313,203
- Total Assets
- DKK 4,313,203
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -5K | 85K | 4.3M | 0 |
| 2024 | - | -6K | -2.5M | 4.2M | 0 |
| 2023 | - | -5K | 10K | 6.7M | 0 |
Official annual report
How creditworthy is FormanBiotech Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
FormanBiotech Holding ApS has published its annual report for 2024. Gross profit came to DKK -5,676, and the net result was DKK -2,512,116.
About FormanBiotech Holding ApS
FormanBiotech Holding ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Victor Forman. The company is owned by Victor Forman. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,876 and a net result of DKK 85,326 compared with DKK -2,512,116 the year before. Equity in the 2025 report amounted to DKK 4,313,203.